Fundamentals of Good Clinical Practice

This webinar presents a survey of the FDA’s Bioresearch Monitoring Program, a series of FDA inspection programs covering regulatory inspections by the FDA of clinical trial sites, sponsors and Clinical Research Organizations, nonclinical testing laboratories, Institutional Review Boards (IRBs) and post marketing adverse event reporting requirements.

Purchase option for this webinar is currently unavailable. Please contact our Customer Care for more info.
Customer Care

Fax: +1-650-362-2367

Email: customercare@fdatrainingalert.com

Follow us:
Description:

This webinar introduces the concept of Good Clinical Practice (GCP), primarily from a US perspective. Participants will learn:

  • Which FDA regulations are within the scope of GCP
  • The legal basis for the GCP requirement for purposes of FDA regulatory compliance
  • The key objectives of GCP
  • Responsibilities of Sponsors of clinical trials and site level investigators
  • The role of Contract Research Organizations (CROs)
  • Where to find additional information about the requirements and the FDA inspection process for Sponsors and for clinical trial sites.
Why Should You Attend:

The FDA and other regulatory agencies around the world both require and expect persons supporting clinical trials to have a solid understanding of GCP concepts. If such understanding is not present, there is a greater risk of noncompliance, which can lead to rejection of study data, delays in product approvals, potential regulatory sanctions and attendant negative publicity. Having an understanding of the requirements better equips personnel to put in place proper policies and procedures to protect patient safety and rights, and to ensure a satisfactory regulatory evaluation, resulting in faster product approvals.

Areas Covered in the Webinar:
  • Which FDA regulations are within the scope of GCP
    • Informed consent
    • Prevention of financial conflict of interest
    • Clinical trial management
    • Adverse event monitoring and reporting
  • The legal basis for the GCP requirement for purposes of FDA regulatory compliance
  • Introduction to key industry guidance about GCP
  • The key objectives of GCP
    • Subject (patient) safety
    • Informed consent
    • Ethics review of clinical trial protocols
    • Data integrity
    • Prevention of diversion of experimental product for non-trial use
  • Responsibilities of Sponsors of clinical trials and site level investigators
  • The role of Contract Research Organizations (CROs)
  • Where to find additional information about GCP requirements and the FDA inspection process for Sponsors and for clinical trial sites.
Who Will Benefit:
  • Executive leadership team
  • Clinical Operations
  • Clinical Quality Assurance
  • Drug safety (pharmacovigilance)
  • Medical Monitor
  • Data Management
  • Clinical Research Associates (site monitors)
  • Quality Assurance Auditors
Instructor Profile:
David L. Chesney David L. Chesney

Principal and General Manager, DL Chesney Consulting LLC

David L. Chesney has a combination of 52 years experience, 23 with the FDA in an inspection and enforcement capacity, followed by over 29 years consulting experience with pharmaceutical and medical device companies world wide. He is an experienced and accomplished instructor and public speaker.

He has served as an expert witness in several private litigation matters as well as FDA court cases while with the agency. Mr. Chesney holds a BA degree in biology from California State University Northridge and an MS in Jurisprudence (pharmaceutical and medical device law) and a certificate in health care compliance from Seton Hall University School of Law.

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

You Recently Viewed